Literature DB >> 22325656

Immunoadsorption in patients with haemolytic uraemic syndrome.

Christian Combe, Hoang-Nam Bui, Valérie de Précigout, Gilles Hilbert, Yahsou Delmas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22325656     DOI： 10.1016/S0140-6736(12)60228-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Diarrhea-associated hemolytic uremic syndrome with severe neurological manifestations treated with IgG depletion through immunoadsorption.

Authors:  Benjamin Flam; Peter Sackey; Andreas Berge; Anne C Zachau; Bo Brink; Sigrid Lundberg
Journal:  J Nephrol       Date:  2016-03-19       Impact factor: 3.902

2.  [Treatment of typical hemolytic-uremic syndrome. Knowledge gained from analyses of the 2011 E. coli outbreak].

Authors:  J Menne; J T Kielstein; U Wenzel; R A K Stahl
Journal:  Internist (Berl)       Date:  2012-12       Impact factor: 0.743

Review 3.  Thrombotic microangiopathy and associated renal disorders.

Authors:  Thomas Barbour; Sally Johnson; Solomon Cohney; Peter Hughes
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

4.  Immunoadsorption for paediatric post-diarrhoea haemolytic-uraemic syndrome with severe neurological involvement.

Authors:  C Pietrement; N Bednarek; V Baudouin; M Fila; G Deschênes
Journal:  Clin Kidney J       Date:  2012-10

5.  Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.

Authors:  Yahsou Delmas; Benoît Vendrely; Benjamin Clouzeau; Hiba Bachir; Hoang-Nam Bui; Adeline Lacraz; Sébastien Hélou; Cécile Bordes; Armel Reffet; Brigitte Llanas; Sophie Skopinski; Patrick Rolland; Didier Gruson; Christian Combe
Journal:  Nephrol Dial Transplant       Date:  2013-11-28       Impact factor: 5.992
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.